ResultsIQ

ResultsIQ › Latest results › EP Biocomposites Ltd

EP Biocomposites Ltd Q4 FY26 results press release summary

NSE: EPBIO · BSE: 543595

Results press release of 29 May 2026, summarised by AI from the filing.

Net worth crossed ₹12 cr as on March 31, 2026, with partial debt repayment and improved liquidity.

Key takeaways

  1. Balance sheet Net worth crossed ₹12 cr as on March 31, 2026, with partial debt repayment and improved liquidity.
  2. Returns ROI 14% and ROCE 16% during FY26.
  3. IPO proceeds Utilized towards capacity expansion, working capital, and business growth initiatives.

Original filing on BSE

EP Biocomposites Ltd earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.